Skip to content

Study of the Effects of Chemotherapy on Memory and Other Mental Functions in Women With Breast Cancer

A Prospective, Longitudinal Investigation of the Neuropsychological and Psychosocial Effects of Cancer Therapy

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00260975
Enrollment
112
Registered
2005-12-02
Start date
2001-06-30
Completion date
2008-02-29
Last updated
2017-09-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Keywords

breast cancer, chemotherapy, hormonal therapy, cognitive function, chemo fog

Brief summary

Many breast cancer patients treated with chemotherapy complain of problems with concentration and memory. This has been referred to as chemo fog. The current study is investigating this phenomenon by measuring mental function of breast cancer patients prior to and after exposure to chemotherapy, and by comparing mental function in those patients who receive chemotherapy and those who do not.

Detailed description

Many breast cancer patients treated with chemotherapy complain of problems with concentration and memory. This has been referred to as chemo fog. The current study will investigate this phenomenon by measuring neuropsychological functioning in early stage breast cancer patients prior to and after exposure to chemotherapy, and by comparing change in cognitive function in patients who receive chemotherapy to similar breast cancer patients receiving hormonal therapy only.

Interventions

None listed

Sponsors

Canadian Breast Cancer Foundation
CollaboratorOTHER
Ottawa Hospital Research Institute
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
50 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* stage I or II breast cancer; woman; 50-65 years old; post-menopausal

Exclusion criteria

* history of previous cancer or chemotherapy; significant neurological or psychiatric history

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026